Keywords: mgi, pharma, submits, aquavan, nda, usa, minneapolis

MGI Pharma submits Aquavan NDA in USA

Article | 08 October 2007

Print This

Minneapolis, USA-based MGI Pharma, which is focused in oncology and acute care, says that it has submitted a New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in